Integrative therapies for breast cancer is now endorsed and approved by the American Society of Clinical Oncology

The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO) membership. ASCO considered the guideline for endorsement.

The SIO guideline addressed the use of integrative therapies for the management of symptoms and adverse effects, such as anxiety and stress, mood disorders, fatigue, quality of life, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapy-induced peripheral neuropathy, pain, and sleep disturbance. Interventions of interest included mind and body practices, natural products, and lifestyle modifications.

As part of general recommendation acupressure and acupuncture are recommended for reducing chemotherapy-induced nausea and vomiting.

To read more about the new endorsement by the ASCO please click here

Related Articles